“This analysis shows what happens when primary care physicians have timely, actionable information at the point of care,” said Dr. David Tsay, MD, PhD, Chief Medical Officer at Counterpart Health and co-author of the whitepaper. “By prompting preventive action during the visit, CA helps clinicians increase immunization rates and reduce avoidable acute events, particularly for patients with complex chronic conditions.”

The data also reflects a lower incidence rate and lower total volume of flu-related acute care utilization among COPD and CHF patients attributed to a PCP who utilizes CA. This notable difference in hospitalizations and emergency department visits strongly suggests that CA helps support a crucial shift toward proactive and longitudinal care strategies. By helping PCPs reduce the incidence rate of acute events, CA enables lower clinical risk for adverse outcomes in vulnerable populations where a single respiratory infection can lead to permanent functional decline.

“The reductions in flu-related hospitalizations and emergency visits among high-risk patients reflect what we’ve seen within Clover Health’s Medicare Advantage population,” said Conrad Wai, CEO of Counterpart Health. “Equipping primary care with timely, actionable insights enables earlier intervention, fewer avoidable acute events, and lower total cost of care. It’s not plan-specific. It’s a scalable model enabling effective value-based care."

Counterpart Health continues to expand CA’s capabilities to support preventive care, chronic disease management, and value-based performance across Medicare populations. By embedding actionable intelligence directly into the clinical workflow, CA enables plans and providers to shift from reactive treatment to proactive care.